APOTEA

Apotea is an online pharmacy and e-commerce retailer operating in Sweden and Norway. The company sells prescription medicines, health and hygiene products, vitamins, and dietary supplements. Its business model includes logistics operations, personnel leasing to related companies, and market contributions. Apotea serves consumers in the Nordic region through its digital platform and physical prescription branches.

Summarised from the company's own disclosures, fiscal year ended Dec 2025

Industry Pharmaceutical Retailers Homepage ir.apotea.se
Sector Healthcare IR page ir.apotea.se
Tags
online pharmacy, prescription medicines, health products, vitamins, dietary supplements, e-commerce, logistics, personnel leasing
Press page —

Metrics

Valuation  
Market cap kr 7.487B
Market cap (USD) $ 740.503M
P/E 33.18
PEG 0.26
P/BV 8.71
P/S 1.04
P/OCF 22.46
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE 30.3%
ROI 26.3%
ROIC 27.1%
Profit margin 3.1%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y Yes
Revenue up 5y —
Earnings growth 3y (net profit CAGR) 125.7%
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock Yes
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 50.0%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Revenue 7.203B 6.541B 5.45B 4.883B 4.58B
Net profit 226.3M 212M 87M 19.9M 104.9M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Share price 86.85 84.95 — — —
Price performance 12m 0.02 — — — —

Filed figures

Figure Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (SEK) — 289M 359M 355M
↳ YoY growth +24.0% -0.9%
Other receivables (SEK) — 46.2M 47.9M 62M
Borrowings, current (SEK) — 66.9M 79.6M 21.6M
Lease liabilities (SEK) — 195M 162M 309M
Cash and deposits (SEK) 18.2M 19.1M 27.3M 30.6M
Intangible assets (SEK) — 23.7M 18.1M 14.1M
Right-of-use assets (SEK) — 192M 159M 307M
Net debt (borrowings + leases - cash) (SEK) — 243M 215M 300M
Cash flow detail
Operating cash flow (SEK) — 216M 206M 333M
Purchases of property, plant and equipment (SEK) — -120M -163M -213M
Purchases of intangible assets (SEK) — -1.2M -1M -2.6M
Change in receivables (cash effect) (SEK) — -41.7M -80.4M -11.3M
Change in inventories (cash effect) (SEK) — -20M -152M -90.3M
Change in payables (cash effect) (SEK) — 82.3M 76.5M 15.8M
Share buybacks (cash effect) (SEK) — -11.8M -8.4M —
Interest paid (cash effect) (SEK) — -6.3M -5.2M -11.3M
Income taxes paid (cash effect) (SEK) — -25.9M -29.3M -40.1M
Operating cash flow before change in receivables (SEK) — 258M 287M 345M
Free cash flow (OCF - PPE - intangibles) (SEK) — 94.7M 42.4M 118M
Income detail
Total comprehensive income (SEK) — 82.3M 211M 224M
Comprehensive income to owners (SEK) — 86.8M 213M 227M
Reported — — — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

Apotea (ticker APOTEA), listed in Sweden.

ETFs Holding Apotea

ETF Weight in ETF Shares Market value As of
AVDV 0.05% 904,786 $ 9.098M Nov 16, 2026
AVDS 0.03% 11,967 $ 120.336K Nov 16, 2026
AVSD 0.01% 5,027 $ 50.55K Nov 16, 2026
DFIS 0.01% 30,247 $ 301.551K Nov 12, 2026
DFSI 0.00% 3,115 $ 31.055K Nov 12, 2026
DFIC 0.00% 16,180 $ 161.309K Nov 12, 2026
DFAX 0.00% 2,663 $ 26.549K Nov 12, 2026
DFAI 0.00% 1,830 $ 18.244K Nov 12, 2026
AVDE 0.00% 58,320 $ 586.447K Nov 16, 2026